Individual | Age | Gender | CORD symptoms | BCVA (OD/OS) | IOP (OD/OS mmHg) | Fundus | FAF | OCT |
---|---|---|---|---|---|---|---|---|
II-2 | 55 | F | no | 1.0/1.0 | 16/16 | normal | normal | normal |
II-3 | 50 | M | early nyctalopia, progressive visual impairment, color vision defects, decreased sensitivity in the central visual field, followed by peripheral vision | Fc/30 cm/Fc/20 cm | 12/15 | bone spicule pigmentation | hypofluorescent lesion at the perifoveal region | atrophy in the outer retinal layer |
II-4 | 47 | F | no | 0.8/0.6 | 17/17 | normal | normal | normal |
III-1 | 32 | M | early nyctalopia, progressive visual impairment, color vision defects, decreased sensitivity in the central visual field, followed by peripheral vision | 0.07/0.25 | 11/12 | bone spicule pigmentation | hypofluorescent lesion at the perifoveal region | atrophy in the outer retinal layer |
III-2 | 19 | M | early nyctalopia, progressive visual impairment, color vision defects, decreased sensitivity in the central visual field, followed by peripheral vision | 0.04/0.04 | 17/16 | bone spicule pigmentation | hypofluorescent lesion at the perifoveal region | atrophy in the outer retinal layer |
III-5 | 23 | M | early nyctalopia, progressive visual impairment, color vision defects, decreased sensitivity in the central visual field, followed by peripheral vision | 0.25/0.3 | 15/18 | bone spicule pigmentation | hypofluorescent lesion at the perifoveal region | atrophy in the outer retinal layer |